China to cut tariffs on more Canadian exports, including pork and seafood
China will cut tariffs on more Canadian exports, including pork and seafood, after talks between Chinese President Xi Jinping and Canadian Prime Mi...
Around 100 boys in Georgia are living with Duchenne muscular dystrophy - a disease that has never allowed a child to grow old. Their parents have spent weeks protesting outside government offices, saying their sons cannot wait any longer for treatment.
“Give our kids the medicine. What if it was your child?”
Those words - scrawled on banners and shouted into the cold Tbilisi wind - have become the rallying cry of Georgian parents camped outside the country’s Government Chancellery since 20 April. Day and night, through rain, bitter winds and near-freezing temperatures, they have demanded access to medicines that could slow a disease that is, without exception, fatal.
They are not asking for a cure. There is no cure. They are asking for a chance to slow the progression of a condition that destroys children’s bodies year by year.
Duchenne muscular dystrophy (DMD) is a rare genetic disorder that destroys muscle tissue from birth. It affects almost exclusively boys because the faulty gene sits on the X chromosome, and it progresses with relentless efficiency. By their teenage years, most boys with Duchenne require a wheelchair. Later, their hearts and lungs begin to fail. Average life expectancy is typically between 20 and 30 years.
In Georgia - a country of fewer than four million people on the edge of the Caucasus - around 100 children are living with the diagnosis. Anewz has spoken to several of their parents, as well as the organisation leading the campaign, over recent weeks. Their accounts paint a picture of families exhausted by grief and driven by anger as they watch their sons deteriorate while political and bureaucratic deadlock continues.
“Every passing year means that their life is being taken away. Neither birthdays nor New Year - nothing makes us happy anymore.”
Tako Gogoladze, the mother of nine-year-old Andria Tevzadze, has attended almost every night of the protest. Speaking to Anewz, she described the reality of living with Duchenne.
“From about the age of 10, children are confined to a wheelchair,” she said. “Then internal pathologies begin - the heart and lungs begin to degenerate, they lose strength in their hands and limbs. Life expectancy is about 18 to 20 years.”
Kakha Tsikarishvili, father of 13-year-old Nikoloz, described the disease in similarly stark terms.
“Duchenne’s disease actually deprives children of their childhood,” he told Anewz. “From about seven years old, it becomes difficult for a child to climb stairs. By 11 or 12, he is in a wheelchair. By 17 or 18, even breathing becomes difficult. By the age of 20, they can only move their fingers.”
Without medical intervention, he said, a fatal outcome before the age of 30 is almost inevitable.
In the past 18 months alone, three Georgian boys with Duchenne have died - aged 17, 22 and 27.
For the first time in the history of Duchenne, treatments now exist that can significantly slow the disease’s progression. They cannot cure or reverse it, but families say they could buy children precious years.
Parents are demanding that the Georgian government fund and import four therapies, all of which have been authorised by major international regulators.
A next-generation anti-inflammatory steroid with significantly fewer side effects than older steroids currently used in Georgia. It was approved by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) in late 2023, and by the NHS in the UK in December 2024. It is already funded in countries including Germany, Austria and the UK.
The first non-steroidal Duchenne treatment, approved by the FDA in March 2024 and by the EMA in June 2025. Taken daily as a pill or syrup, it reduces muscle inflammation and slows muscle deterioration. It is already in use in Italy, Germany and other countries, while Georgian children living abroad are already receiving it.
These gene-targeted treatments help the body produce a partially functional form of the dystrophin protein, slowing disease progression. Several versions have been authorised by the FDA and are already in use in the U.S. and Japan. Three are registered in Georgia but have never been imported.
A one-time intravenous gene therapy designed to deliver a functioning gene to muscle cells. It is also the most expensive option, costing around $3 million per patient. The therapy received FDA authorisation in 2023 and 2024 but has not been approved in Europe. It remains under clinical monitoring following rare but serious adverse events and is currently restricted to ambulant patients.
Zakro Gvishiani, chair of the organisation Let’s Fight Duchenne Muscular Dystrophy Together, told Anewz that even limited improvements can transform a child’s life.
“We have a Georgian child with American citizenship who has undergone gene therapy,” he said. “Until recently, he could not even manage one floor of stairs. Now he can handle nine floors independently.”
Parents insist they are not asking the government to take unreasonable risks. They argue that the FDA and EMA — widely regarded as two of the world’s strictest medicines regulators - have already carried out extensive assessments of the drugs.
International pharmacoeconomics expert Tiniko Turdziladze, speaking to a Georgian media outlet, said regulators weigh risks differently in rare diseases such as Duchenne because the disease itself is so devastating.
“The concept is to assess the risk of the disease and the benefit of the drug,” she said. “In the case of Duchenne, the risk is very high - therefore, drugs are released with less data, and observation continues.”
“Research is underway globally and this disease may actually be cured in a few years. That is why it is so important for us to take these medications today — so that our children are still alive to receive whatever comes next.”
The Georgian government has acknowledged that Duchenne is a healthcare priority, but says questions remain over the safety and effectiveness of the medicines parents are demanding.
This part one of a three part series about Duchenne treatment access in Georgia. In part two, Nini Nikoleishvili speaks to more campaigning families and looks at why the situation in Georgia differs to several other European countries.
"When we return home, the children ask us: will there be medicine soon? Will we be okay? Can I run like all the other children?"
U.S. President Donald Trump is expected to arrive in Manila on Tuesday, 17 November, for a special summit with Southeast Asian leaders, as Washington seeks to strengthen regional economic and security ties amid trade tensions and growing competition with China.
Robert Pattinson has been named the next James Bond, with Amazon MGM Studios confirming the British actor will succeed Daniel Craig as 007 in a new film directed by Denis Villeneuve.
Yemeni forces fighting for the internationally recognised Saudi-backed government said on Sunday that they were withdrawing from an area overlooking the strategic Bab el-Mandeb Strait, leaving the Iran-aligned Houthis in control.
Iran and Oman have nearly finished a joint plan governing navigation through the Strait of Hormuz, an Iranian lawmaker said on Monday, as Tehran reported fresh explosions involving oil tankers in the strategic waterway.
The U.S. Embassy in Bahrain urged American citizens on Sunday (15 November) to exercise “heightened vigilance” amid escalating regional security threats, following Iranian aerial attacks on the kingdom and intensified Houthi operations across the Middle East.
Kyrgyzstan's economy expanded by 10.5 per cent in the first ten months of 2026, but rising prices for food, goods and services have raised questions about how much households are benefiting from the country's economic growth.
Uzbekistan is in talks with Kazakhstan and Kyrgyzstan over a joint customs system aimed at cutting border delays and speeding up freight transport. The proposed ‘One Stop’ system would eliminate duplicate inspections and simplify procedures at selected crossings.
Bahrain has sentenced dozens of people, most of them Shia Muslim clerics, to life in prison over an alleged plot involving Iran’s Revolutionary Guards to overthrow the government, as rights groups raise concerns about torture and coerced confessions.
Türkiye has brought a trilateral defence pact with Pakistan and Saudi Arabia into force and signed a separate agreement with Qatar, as Ankara moves to strengthen its regional security partnerships.
Afghanistan and Iran agreed to expand border facilities and operate customs around the clock during talks in Tehran on Sunday (15 November) between Afghan Finance Minister Mohammad Nasir Akhund and Iranian Foreign Minister Abbas Araghchi, as both countries seek to increase trade.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment